Literature DB >> 16896782

Data mining in pharmacovigilance: lessons from phantom ships.

Manfred Hauben, Lester Reich, Eugène P Van Puijenbroek, Charles M Gerrits, Vaishali K Patadia.   

Abstract

Mesh：

Year:  2006        PMID： 16896782     DOI： 10.1007/s00228-006-0181-4

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  31 in total

1.  Underreporting of adverse drug reactions: attitudes of Irish doctors.

Authors:  D Williams; J Feely
Journal:  Ir J Med Sci       Date:  1999 Oct-Dec       Impact factor: 1.568

2.  [Pharmacovigilance: a case of phantom ships and Russian roulette].

Authors:  B H Ch Stricker
Journal:  Ned Tijdschr Geneeskd       Date:  2002-07-06

Review 3.  Not all sulfa drugs are created equal.

Authors:  Steven M Toler; Ignacio Rodriguez
Journal:  Ann Pharmacother       Date:  2004-10-19       Impact factor: 3.154

4.  Data mining in pharmacovigilance: the need for a balanced perspective.

Authors:  Manfred Hauben; Vaishali Patadia; Charles Gerrits; Louisa Walsh; Lester Reich
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 5.  Sulfonamide cross-reactivity: fact or fiction?

Authors:  Kelly K Johnson; David L Green; Jason P Rife; Lynn Limon
Journal:  Ann Pharmacother       Date:  2005-01-11       Impact factor: 3.154

Review 6.  Evaluating diagnostic tests with imperfect standards.

Authors:  P N Valenstein
Journal:  Am J Clin Pathol       Date:  1990-02       Impact factor: 2.493

7.  Attitudes to adverse drug reaction reporting by medical practitioners in a Northern Italian district.

Authors:  M Cosentino; O Leoni; F Banfi; S Lecchini; G Frigo
Journal:  Pharmacol Res       Date:  1997-02       Impact factor: 7.658

Review 8.  Levodopa therapy and the risk of malignant melanoma.

Authors:  J F Siple; D C Schneider; W A Wanlass; B K Rosenblatt
Journal:  Ann Pharmacother       Date:  2000-03       Impact factor: 3.154

9.  Myocardial infarction and nicotine patch: a contributing or causative factor?

Authors:  A Dacosta; J M Guy; B Tardy; R Gonthier; L Denis; M Lamaud; A Cerisier; H Verneyre
Journal:  Eur Heart J       Date:  1993-12       Impact factor: 29.983

10.  Ocular side effects of the lipid-lowering drug simvastatin? A one year follow-up.

Authors:  W Behrens-Baumann; A Morawietz; J Thiery; C Creutzfeldt; D Seidel
Journal:  Lens Eye Toxic Res       Date:  1989
View more
  6 in total

1.  Potential use of data-mining algorithms for the detection of 'surprise' adverse drug reactions.

Authors:  Manfred Hauben; Sebastian Horn; Lester Reich
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

2.  Illusions of objectivity and a recommendation for reporting data mining results.

Authors:  Manfred Hauben; Lester Reich; Charles M Gerrits; Muhammad Younus
Journal:  Eur J Clin Pharmacol       Date:  2007-03-16       Impact factor: 2.953

3.  Gold standards in pharmacovigilance: the use of definitive anecdotal reports of adverse drug reactions as pure gold and high-grade ore.

Authors:  Manfred Hauben; Jeffrey K Aronson
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

4.  Impact of safety alerts on measures of disproportionality in spontaneous reporting databases: the notoriety bias.

Authors:  Antoine Pariente; Fleur Gregoire; Annie Fourrier-Reglat; Françoise Haramburu; Nicholas Moore
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

5.  Evolution and translation of research findings: from bench to where?

Authors:  John P A Ioannidis
Journal:  PLoS Clin Trials       Date:  2006-11-17

6.  The use of older studies in meta-analyses of medical interventions: a survey.

Authors:  Nikolaos A Patsopoulos; John Pa Ioannidis
Journal:  Open Med       Date:  2009-05-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.